MGNX - MACROGENICS INC

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 14.56

Open

$ 15.32

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 14.24 - $ 15.32

52 Week Range

$ 4.29 - $ 21.88

Volume

649,535

Average Volume

Market Cap

901.69M

Beta (5Y Monthly)

$ 1.73

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-07-2024	12-31-2023	10-K
2	11-06-2023	09-30-2023	10-Q
3	08-09-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	03-15-2023	12-31-2022	10-K
6	11-03-2022	09-30-2022	10-Q
7	08-08-2022	06-30-2022	10-Q
8	05-03-2022	03-31-2022	10-Q
9	02-24-2022	12-31-2021	10-K
10	11-02-2021	09-30-2021	10-Q
11	07-29-2021	06-30-2021	10-Q
12	04-29-2021	03-31-2021	10-Q
13	02-25-2021	12-31-2020	10-K
14	11-04-2020	09-30-2020	10-Q
15	07-31-2020	06-30-2020	10-Q
16	05-05-2020	03-31-2020	10-Q
17	02-25-2020	12-31-2019	10-K
18	11-06-2019	09-30-2019	10-Q
19	07-31-2019	06-30-2019	10-Q
20	05-01-2019	03-31-2019	10-Q
21	02-26-2019	12-31-2018	10-K
22	11-07-2018	09-30-2018	10-Q
23	08-07-2018	06-30-2018	10-Q
24	05-07-2018	03-31-2018	10-Q
25	02-27-2018	12-31-2017	10-K
26	11-08-2017	09-30-2017	10-Q
27	08-02-2017	06-30-2017	10-Q
28	05-03-2017	03-31-2017	10-Q
29	02-28-2017	12-31-2016	10-K
30	11-02-2016	09-30-2016	10-Q
31	08-03-2016	06-30-2016	10-Q
32	05-04-2016	03-31-2016	10-Q
33	02-29-2016	12-31-2015	10-K
34	11-04-2015	09-30-2015	10-Q
35	08-05-2015	06-30-2015	10-Q
36	05-06-2015	03-31-2015	10-Q
37	03-03-2015	12-31-2014	10-K
38	11-12-2014	09-30-2014	10-Q
39	08-05-2014	06-30-2014	10-Q
40	05-06-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Macrogenics shares are trading higher afte...
04/09/2024 12:28:55

TD Cowen Upgrades Macrogenics to Buy
04/09/2024 10:37:43

TD Cowen analyst Boris Peaker upgrades Macrogenics (NASDAQ:MGNX) from Hold to Buy.

look-out-for-these-6-stocks-as-analysts-predicts-major-gains-one-up-to-82

Look Out For These 6 Stocks As Analysts Pr...
04/05/2024 06:15:54

Investment analysts have revised their price targets upwards for six major stocks this week, with one company expected to see a...

MacroGenics Analyst Impressed By Improved ...
04/04/2024 18:15:59

Update on MacroGenics Inc's Phase 2 TAMARACK study of vobramitamab duocarmazine (vobra duo) for metastatic castration-resis...

why-staar-surgical-shares-are-trading-higher-by-around-13-here-are-other-stocks-moving-in-thursdays-mid-day-session

Why STAAR Surgical Shares Are Trading High...
04/04/2024 17:21:21

Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong prelimi...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
04/04/2024 16:31:14

The Latest Analyst Ratings For Macrogenics
04/04/2024 16:01:05

JMP Securities Reiterates Market Outperfor...
04/04/2024 12:56:15

JMP Securities analyst Silvan Tuerkcan reiterates Macrogenics (NASDAQ:MGNX) with a Market Outperform.

simulations-plus-posts-upbeat-joins-levi-strauss-blackberry-and-other-big-stocks-moving-higher-in-thursdays-pre-market-session

Simulations Plus Posts Upbeat, Joins Levi ...
04/04/2024 09:18:40

U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday.

MacroGenics Says TAMARACK Study Data Will ...
04/03/2024 20:33:07

Citigroup Maintains Buy on Macrogenics, Ra...
03/11/2024 15:59:12

Citigroup analyst Yigal Nochomovitz maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $13 to $25.

JMP Securities Maintains Outperform on Mac...
03/11/2024 11:23:20

JMP Securities analyst Silvan Tuerkcan maintains Macrogenics (NASDAQ:MGNX) with a Outperform and raises the price target fro...

HC Wainwright & Co. Maintains Neutral on M...
03/11/2024 10:43:02

HC Wainwright & Co. analyst Robert Burns maintains Macrogenics (NASDAQ:MGNX) with a Neutral and raises the price target ...

BMO Capital Maintains Outperform on Macrog...
03/08/2024 16:22:30

BMO Capital analyst Etzer Darout maintains Macrogenics (NASDAQ:MGNX) with a Outperform and raises the price target from $18 ...

Stifel Maintains Buy on Macrogenics, Raise...
03/08/2024 15:42:11

Stifel analyst Stephen Willey maintains Macrogenics (NASDAQ:MGNX) with a Buy and raises the price target from $17 to $29.

Barclays Maintains Overweight on Macrogeni...
03/08/2024 11:06:09

Barclays analyst Peter Lawson maintains Macrogenics (NASDAQ:MGNX) with a Overweight and raises the price target from $23 to ...

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
03/07/2024 21:31:03

Macrogenics: Q4 Earnings Insights
03/07/2024 21:15:28

Macrogenics Q4 2023 GAAP EPS $(0.750), Sal...
03/07/2024 21:14:32

Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.750) per share. The company reported $10.720 million in sales this ...

Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...